- NSE
- IPCALAB
- BSE
- 524494
- ISIN
- INE571A01038
IPCA LABORATORIES
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,959.70
+₹17.90 (+0.92%)
NSE close ·
IPCA LABORATORIES closed at ₹1,959.70 on 9 Nov 2026, up 0.92% on the day, and is up 48.65% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹1,302.00 to ₹2,009.60.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹49,718 Cr
- P/E (TTM)
- 35.5
- Industry P/E
- 35.5
- EPS (TTM)
- ₹55.28
- P/B
- 5.73
- Book value
- ₹342.06
- ROE
- 16.2%
- ROCE
- 21.8%
- Debt/equity
- 0.07
- Operating margin
- 17.8%
- Net margin
- 13.4%
- Dividend yield
- 0.31%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +12.46% | +15.94% |
| Net profit | +73.81% | +44.83% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹2,935 Cr | ₹389 Cr | +38.78% | ₹14.79 |
| Jun 2026 | ₹2,813 Cr | ₹424 Cr | +82.18% | ₹15.84 |
| Mar 2026 | ₹2,482 Cr | ₹307 Cr | +379.28% | ₹11.79 |
| Dec 2025 | ₹2,413 Cr | ₹364 Cr | +31.59% | ₹12.86 |
| Sep 2025 | ₹2,584 Cr | ₹281 Cr | +14.15% | ₹11.14 |
| Jun 2025 | ₹2,342 Cr | ₹233 Cr | +16.95% | ₹9.19 |
| Mar 2025 | ₹2,273 Cr | ₹63.99 Cr | +4,711.28% | ₹2.67 |
| Dec 2024 | ₹2,265 Cr | ₹276 Cr | +25.05% | ₹9.78 |
Armor risk check
IPCA LABORATORIES moves about 2× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is IPCA LABORATORIES's share price today?
IPCA LABORATORIES (NSE: IPCALAB) closed at ₹1,959.70 on 9 Nov 2026, up 0.92% from the previous close of ₹1,941.80. It traded between ₹1,928.30 and ₹1,991.70 that day.
What are IPCA LABORATORIES's 52-week high and low?
Over the last 52 weeks IPCA LABORATORIES traded between ₹1,293.90 and ₹2,038.00, adjusted for splits and bonuses.
What are IPCA LABORATORIES's NSE symbol, BSE code and ISIN?
IPCA LABORATORIES has NSE symbol IPCALAB, BSE code 524494, ISIN INE571A01038.
How has IPCA LABORATORIES performed over 1, 3 and 5 years?
IPCA LABORATORIES's share price return: 1Y +48.65%, 3Y +23.26% a year, 5Y +12.43% a year. Dividends are not included.
Does IPCA LABORATORIES pay a dividend?
Yes. IPCA LABORATORIES's latest dividend went ex on 7 Aug 2026: ₹6.00 per share. Dividends over the past year come to a yield of 0.31% at the latest close.
What is IPCA LABORATORIES's P/E ratio?
IPCA LABORATORIES's P/E ratio is 35.5: the ₹1,959.70 close on 9 Nov 2026 over trailing twelve-month EPS of ₹55.28 (consolidated, four quarters to 30 Sep 2026).
What is IPCA LABORATORIES's market cap?
IPCA LABORATORIES's market cap is ₹49,718 Cr at the close on 9 Nov 2026.
Which sector is IPCA LABORATORIES in?
IPCA LABORATORIES is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how IPCA LABORATORIES fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app